Preterm birth is the leading cause of newborn death worldwide and is associated with 1 9
INTRODUCTION

9
Premature birth, defined as delivery before 37 weeks of gestation, occurs in 4 0
11.1% of pregnancies worldwide and is associated with neonatal morbidity and pregnancy, and decidual senescence often result in spontaneous preterm labor (sPTL).
4
There is a paucity of research examining transcriptomic changes that occur during mechanisms underlying this heterogeneous syndrome [3] . Therefore, there is a crucial relating to sPTL. peripheral monocytes to previously published miRNA data from matched plasma and
EVs from the same patients (GSE106224) [18] , as well as mRNA expression from whole 1 4 1 blood and peripheral monocytes (GSE96097) [17] .
4 2
Putative miRNA targets were detected using the quantitative model TargetScan (V. 7.0, and has the best predictive performance compared to comparable tools [22] . MiRNA-
target gene relationships were identified in whole blood and peripheral monocytes by miRNA, we used only mRNA targets with an absolute value of "context++" score (a 1 4 8 metric of miRNA target prediction accuracy used by TargetScan) which was higher than were clustered into ClueGO groups based on the similarity in the number of genes in the women undergoing PTL compared to women who delivered at term ( Figure 1A -B,
supplemental table 1). In whole blood, 6 miRNAs were higher and 3 miRNAs were Figure 2C . We stratified women into high and low miR-151 expression based on miR-
151 mapped reads, using a cutoff of miR-151a-5p >15 and miR-151b-3p >10 log CPM MiR-1291-5p expression was significantly increased in whole blood of women
undergoing sPTL(Log fold change 1.12, FDR adjusted q=2.22x10 -4 ), but decreased in Comparison of expression differences across blood compartments
In our prior analysis of plasma from same patients from the OBS cohort, we 2 0 6 identified significant differences in concentration of 132 miRNAs in whole plasma, EVs
and EV depleted plasma [18] . Five of these miRNAs were also significantly different in 2 0 8 monocytes, and three miRNAs were significantly different in whole blood 2 0 9
(supplemental table 2). We examined correlations of these 8 miRNAs that were
significantly upregulated in plasma samples as well as in whole blood and monocytes
from the same patients (supplemental figure 2, N=44 samples with plasma and whole
blood RNAseq data, N=42 samples with monocyte and whole blood sRNA sequencing 2 1 3 data, and N=14 samples with RNAseq data in EVs and monocytes/whole blood). We observed significant positive correlations (p<0.05) between whole blood miRNA 2 2 3 levels and the levels in plasma and EVs in the 3 miRNAs significantly associated with
sPTL in the previous studies: (1) MiR-374a-5p was decreased in both plasma and whole
blood of women undergoing sPTL, (2) miR-381-3p was decreased in plasma but
increased in whole blood of women undergoing sPTL, and (3) miR495-5p was decreased 2 2 7
in the plasma and extracellular vesicles but increased in the whole blood of women 2 2 8
undergoing sPTL compared to controls. This indicates that there is some overlap in signal 2 2 9 related to sPTL that is detectable across different components of the blood within the 2 3 0 same individuals.
Confirmation of target mRNAs of miRNAs associated with sPTL
We identified the putative mRNA targets of the differentially expressed miRNAs mRNA interactions and has shown to have the highest predictive value compared to 2 3 5 similar tools [22] . From the TargetScan database, we included only the top 50% of mRNA predicted interactions to only those which had a Spearman correlation coefficent with no confirmed mRNA targets.
4 5
In previous transcriptomic analyses from the same patients, we identified 262
genes in monocytes and 181 genes in whole blood which were associated with sPTL[17] .
4 7
Here, we compared the changes in mRNA expression related to sPTL and the confirmed 2 4 8 miRNA target genes we have identified in this current study (Figure 3) . In whole blood, 2 4 9
9 of the 181 DEGs were confirmed miRNA targets of 3 differentially expressed miRNAs
in whole blood (Shown in Figure 3A ). Among these 3 miRNAs in whole blood, miR- the strongest regulator, and was negatively associated with 11 of the 28 genes which are positively associated with sPTL, including IL1B, IL1R1 and CD177 ( Figure 3B ). In both whole blood and monocytes, the direction of the associations with PTL is congruent with miRNA is negatively correlated with mRNAs that are negatively associated with PTL).
6 0
We also examined mRNAs which were in the same genomic region as the miRNAs in 2 6 1 our study, but found that none of the associated mRNAs were statistically significantly 2 6 2 associated with sPTL in monocytes and whole blood leukocytes. This integrated analysis 2 6 3
suggests that the miRNAs identified here may play a role in the transcriptional regulation
of genes associated with sPTL in monocytes and whole blood leukocytes. We performed enrichment analysis to identify gene sets which were overrepresented by the confirmed mRNA targets of the differentially expressed miRNAs 2 6 8 identified in whole blood and monocytes. Using CytoScape application "ClueGO", we identified significantly enriched GO gene sets which were grouped together based on
intersecting common genes, which are shown in Figure 4 , and in supplemental table 4.
7 1
In whole blood, 59 different GO gene sets were significantly enriched for the 303 genes 2 7 2 which were mRNA targets for the 9 miRNAs associated with sPTL in whole blood.
7 3
These gene sets were grouped into 19 ClueGO groups, including 8 distinct groups (i.e. only had 1 GO gene set), and one ClueGO group which contained 22 GO gene sets
including the 5 most significant gene sets: "positive regulation of cytokine production" ,
"positive regulation of adaptive immune response" , "interleukin-2 production" ,
"positive regulation of adaptive immune response based on somatic recombination of
immune receptors built from immunoglobulin superfamily domains" , and" T cell receptor signaling pathway". This diversity of GO gene sets and strong signal indicates based on q value were: "small GTPase mediated signal transduction"," negative role in regulation of these pathways in monocytes.
9 2
The Gene Ontology gene set "positive regulation of interlukin-2 production" was genes, and the differentially expressed miRNAs in both whole blood and monocytes were 17.86% of the total genes in this pathway. In whole blood, 4 miRNAs were identified as 2 9 7
regulators of the 5 genes (CCR2, CD4, MALT1, PDE4B, and CD28). In monocytes, 3
miRNAs were identified as negative regulators of the 5 genes (SASH3, CD83, IL1B,
TNFSF4, and CD28) involved in interleukin signaling ( Table 2) . In this gene set, IL1B
was a target of miR-1291-5p, and IL1B expression was significantly increased in women significantly alters genes involved in production of interleukin 2.
This study is the first comprehensive miRNA profiling of women undergoing 3 0 6 sPTL using small RNA sequencing within both whole blood and peripheral monocytes. with sPTL, which we identified using previously generated RNA sequencing data on monocytes and whole blood of women undergoing sPTL.
Overall, we identified a greater number of miRNAs with concentration changes,
and more genes related to miRNAs associated with sPTL. Additionally, we observed no
congruence in the differential miRNAs identified in monocytes and whole blood. Maternal blood includes three major subsets of immune cells; monocytes, lymphocytes,
and granulocytes, which circulate through gestational tissues including the myometrium, sequencing data derived from monocytes exhibits less cellular heterogeneity and thus
likely has a cleaner signal. We suggest that the signaling we observe in monocytes may 2 miRNAs (miR-151a-5p and or miR-151b-3p ), which are encoded on opposing DNA or if there are physiological shifts in these miRNAs and the genes that they regulate.
Altogether, our work suggests that a stronger signal related to sPTL can be obtained from 3 2 9 monocytes compared to whole blood.
We observed a number of miRNAs which were differentially expressed in in 3 3 1 whole blood and monocytes of women undergoing sPTL which also exhibited significant 3 3 2 concentration differences previously identified in whole plasma, EV-depleted plasma and
EVs in the same population of individuals [18] . We identified fewer differential miRNAs sPTL. This suggests functional signaling that occurs within blood in context of sPTL. In of women at 20 weeks who went on to deliver prematurely [13] . Similarly, we observed 3 3 9
increased levels of this miRNA in whole blood of women who delivered prematurely 3 4 0 compared to TL controls, which supports the potential of this miRNA as biomarkers for In whole blood, 2 of the miRNAs (miR-495-3p and miR-381-3p) with group of imprinted miRNAs located on chromosome 14q32 which is highly produced by the placenta and enters maternal circulation [24] . In plasma samples from the same reflective of concentration changes related to miRNA signals from the developing fetus. We identified mRNAs which were transcriptionally regulated by differentially expressed miRNAs using predicted targets from TargetScan, which were filtered using these predicted targets passed our filter whole blood and 7.29% in monocytes. These are not cell type specific [22] . This analysis was designed to collect miRNA and mRNA 3 6 3 from the same patient, which allowed us to perform correlations and obtain a far more relying solely on miRNA prediction algorithms alone. We used our curated, confirmed miRNA target lists generated to perform an 3 6 7 enrichment analysis of gene sets related to our differentially expressed miRNAs. In 
